EFFECT OF BODY MASS INDEX ON TREATMENT RESPONSE OF BIOLOGIC-/TARGETED SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS

被引：1
|
作者：
Gialouri, C. G. [1 ]
Pappa, M. [2 ]
Evangelatos, G. [2 ]
Nikiphorou, E. [3 ,4 ]
Fragoulis, G. E. [2 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Clin Immunology Rheumatol Unit, Dept Med & Lab 2, Hippokrat Gen Hosp Athens,Med Sch, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Dept Propaedeut Internal Med 1, Rheumatol Unit, Med Sch,Laiko Gen Hosp Athens, Athens, Greece
[3] Kings Coll Hosp London, London, England
[4] Ctr Rheumat Dis, Rheumatol Dept, London, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Inflammatory arthritides; bDMARD; Comorbidities;
D O I：
10.1136/annrheumdis-2023-eular.5979
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0960
引用
收藏
页码：1698 / 1698
页数：1
相关论文
共 50 条
  • [31] A Minority of Patients Utilize Most of Healthcare Resources in Rheumatoid Arthritis, Psoriatic Arthritis, Juvenile Idiopathic Arthritis, and Axial Spondyloarthritis
    Mars, Nina
    Kerola, Anne M.
    Kauppi, Markku J.
    Elonheimo, Outi
    Huvinen, Santeri
    Sokka-Isler, Tuulikki
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [32] PREDICTION OF TREATMENT DISCONTINUATION DUE TO ADVERSE EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS USED BIOLOGICAL DMARDS AND TARGETED SYNTHETIC DMARDS
    Koltsova, E.
    Lukina, G.
    Shmidt, E.
    Lytkina, K.
    Zhilyaev, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1211 - 1211
  • [33] Ultrasound Evaluation of the Efficacy of Biologic and Targeted Synthetic Dmards Toward Rheumatoid Arthritis Patients: Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort in Japan
    Nishino, Ayako
    Kawashiri, Shin-ya
    Kawakami, Atsushi
    Yoshitama, Tamami
    Eiraku, Nobutaka
    Matsuoka, Noki
    Ueki, Yukitaka
    Okada, Akitomo
    Hamada, Hiroaki
    Hidaka, Toshihiko
    Nagano, Shuji
    Tsuru, Tomomi
    Fujikawa, Keita
    Arinobu, Yojiro
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [34] Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis
    Huang, Hua
    Cen, Han
    Zhou, Li
    Wang, Ting-hui
    Qin, Wen
    Xie, Bin-hua
    Xiao, Dong-Mei
    Wu, Xiu-Di
    Wu, Hua-Xiang
    ARCHIVES OF RHEUMATOLOGY, 2019, 34 (04) : 406 - 413
  • [35] IS THE EFFICACY OF BIOLOGIC THERAPEUTIC IN RHEUMATOID ARTHRITIS IS AFFECTED BY BODY MASS INDEX?
    Ferreira, J. F.
    Santiago, M. G.
    Duarte, C.
    Da Silva, J. A. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 883 - 883
  • [36] Body mass index and response to infliximab in rheumatoid arthritis
    Ottaviani, S.
    Gardette, A.
    Tubach, F.
    Roy, C.
    Palazzo, E.
    Gill, G.
    Meyer, O.
    Dieude, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (04) : 478 - 483
  • [37] Body mass index and response to abatacept in rheumatoid arthritis
    Gardette, Anais
    Ottaviani, Sebastien
    Sellam, Jeremie
    Berenbaum, Francis
    Liote, Frederic
    Fautrel, Bruno
    Palazzo, Elisabeth
    Meyer, Alain
    Sibilia, Jean
    Dieude, Philippe
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 (12) : 1048 - 1052
  • [38] Body Mass Index and response to rituximab in rheumatoid arthritis
    Ottaviani, Sebastien
    Gardette, Anais
    Roy, Carine
    Tubach, Florence
    Gill, Ghislaine
    Palazzo, Elisabeth
    Meyer, Olivier
    Dieude, Philippe
    JOINT BONE SPINE, 2015, 82 (06) : 432 - 436
  • [39] COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, AND PSORIATIC ARTHRITIS IN ROMANIA
    Codreanu, C.
    Mogosanu, C.
    Joita, M.
    Purcaru, O.
    VALUE IN HEALTH, 2014, 17 (07) : A379 - A379
  • [40] Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs
    Kalweit, Maria
    Burden, Andrea. M. H.
    Boedecker, Joschka
    Hugle, Thomas H.
    Burkard, Theresa
    PLOS COMPUTATIONAL BIOLOGY, 2023, 19 (06)
12345